Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
registry · NCT04879628 · Structured source fields
Source date: Sep 28, 2026 · Checked: Nov 16, 2026
Evidence location: protocolSection: identificationModule, statusModule, conditionsModule, armsInterventionsModule, designModule, outcomesModule, eligibilityModule, contactsLocationsModule, sponsorCollaboratorsModule; hasResults
Status: ACTIVE_NOT_RECRUITING. Phase: PHASE2. Conditions: Multiple Sclerosis.
Open original source